Clinical Trial Update: T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating T4N5 liposomal lotion to prevent recurrence of nonmelanoma skin cancer in kidney transplant patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Basal Cell Carcinoma of the Skin
• Nonmelanoma Skin Cancer
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• T4N5 Liposomal Lotion (liposomal photolyase-containing topical lotion (T4N5 liposomal lotion))

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Actinic Keratosis, Basal Cell Carcinoma of the Skin | Phase 2 | Status: COMPLETED